Cargando…
Implementation of Mass Cytometry for Immunoprofiling of Patients with Solid Tumors
Monitoring immune responses to solid cancers may be a better prognostic tool than conventional staging criteria, and it can also serve as an important criterion for the selection of individualized therapy. Multiparametric phenotyping by mass cytometry extended possibilities for immunoprofiling. Howe...
Autores principales: | Poláková, Ingrid, Pelák, Ondřej, Thürner, Daniel, Pokrývková, Barbora, Tachezy, Ruth, Kalina, Tomáš, Šmahel, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388349/ https://www.ncbi.nlm.nih.gov/pubmed/30886872 http://dx.doi.org/10.1155/2019/6705949 |
Ejemplares similares
-
ARG1 mRNA Level Is a Promising Prognostic Marker in Head and Neck Squamous Cell Carcinomas
por: Pokrývková, Barbora, et al.
Publicado: (2021) -
Immunoprofiling of Drosophila Hemocytes by Single-cell Mass Cytometry
por: Balog, József Á., et al.
Publicado: (2021) -
Experimental Combined Immunotherapy of Tumours with Major Histocompatibility Complex Class I Downregulation
por: Grzelak, Adrianna, et al.
Publicado: (2018) -
PD1(+)CD8(+) Cells Are an Independent Prognostic Marker in Patients with Head and Neck Cancer
por: Pokrývková, Barbora, et al.
Publicado: (2022) -
Detailed Characteristics of Tonsillar Tumors with Extrachromosomal or Integrated Form of Human Papillomavirus
por: Pokrývková, Barbora, et al.
Publicado: (2019)